Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
On February 26, 2016, Patrick Wen, MD, and David Reardon, MD, discussed the latest research and treatments for patients with brain tumors, including glioblastomas
and low-grade gliomas. Their special focus was on emerging treatments such as immunotherapy, precision cancer medicine, and targeted therapies.
Dr. Wen is the director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute and a professor of neurology at Harvard Medical School. Dr. Reardon is the clinical director of Dana-Farber's Center
for Neuro-Oncology and an associate professor of medicine at Harvard Medical School.
Brain tumor symptoms and treatmentImmunotherapy for brain cancer
The basic science of brain tumorsBrain tumor diagnosis is a collaborative effort
New Patient Appointments
For adults: 877-442-3324For children: 888-733-4662
Video Webchat Series
Dana-Farber's Video Webchat Series features the latest in cancer news and information from top doctors and researchers as well as patients and caregivers. View our upcoming and previous webchat topics.